Your browser doesn't support javascript.
loading
[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. / Unité de greffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Faucher, Catherine; Adam, Catherine; Bancillon, Nelly; Bertrand, Elisabeth; Colledani, Fabienne; de Berranger, Eva; Denis, Virginie; Girard, Isabelle; Hamzy, Fati; Loukili, Noureddine; Mannone, Lionel; Mercier, Lara; Perrin, Agnes; Vasseur, Alyette; Asma, Quessar; Bompoint, Caroline; Yafour, Nabil; Yakoub-Agha, Ibrahim; Jost, Edgar.
Afiliação
  • Faucher C; Unité d'hématologie, institut Paoli Calmettes, 232, boulevard Sainte-Marguerite, 13273 Marseille, France.
  • Adam C; Hématologie pôle IUC oncopole CHU, institut universitaire du cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31059 Toulouse, France.
  • Bancillon N; CHU d'Angers, service d'hématologie, 4, rue Larrey, 49933 Angers, France.
  • Bertrand E; Centre Henri Becquerel, cadre du département d'hématologie, rue d'Amiens, CS11516, 76038 Rouen cedex 1, France.
  • Colledani F; Service d'hématologie greffe de l'hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75010 Paris, France.
  • de Berranger E; CHRU Lille, service d'hématologie pédiatrique, avenue Eugene Avinee, 59037 Lille, France.
  • Denis V; Centre Henri Becquerel, département hématologie, rue d'Amiens, CS11516, 76038 Rouen cedex 1, France.
  • Girard I; CHU Rennes, service hématologie pédiatrique, 16, boulevard de Bulgarie, 35000 Rennes, France.
  • Hamzy F; Service d'hématologie greffe de l'hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75010 Paris, France.
  • Loukili N; CHRU de Lille, service de gestion risque infectieux et des vigilances, 2, avenue Oscar Lambret, 59037 Lille cedex, France.
  • Mannone L; CHU de Nice, hôpital l'Archet 1, service d'hématologie clinique unité de greffe, 151, route Saint-Antoine Ginestière, 06202 Nice, France.
  • Mercier L; Hématologie pôle IUC oncopole CHU, institut universitaire du cancer de Toulouse, 1, avenue Irène Joliot-Curie, 31059 Toulouse, France.
  • Perrin A; CHRU de Lille, service de gestion risque infectieux et des vigilances, 2, avenue Oscar Lambret, 59037 Lille cedex, France; CHRU de Lille, service des maladies du sang, 2, avenue Oscar Lambret, 59037 Lille cedex, France.
  • Vasseur A; CHRU de Lille, service des maladies du sang, 2, avenue Oscar Lambret, 59037 Lille cedex, France.
  • Asma Q; Hôpital 20-Août de Casablanca, 6, rue Lahssen Elaarjoun, Casablanca 20250, Maroc.
  • Bompoint C; CHU Montpellier, 371, avenue du Doyen Gaston Giraud, 34090 Montpellier, France.
  • Yafour N; Service d'hematologie et de therapie cellulaire, établissement hospitalier et universitaire 1(er)-Novembre 1954, BP 4166, 31000 Ibn Rochd, Oran, Algérie; Université d'Oran 1, Ahmed Ben Bella, faculté de médecine, Oran, Algérie.
  • Yakoub-Agha I; CHRU de Lille, service des maladies du sang, 2, avenue Oscar Lambret, 59037 Lille cedex, France; LIRIC, Université de Lille2, Inserm U995, 59000 Lille, France.
  • Jost E; University Hospital RWTH Aachen, medical faculty, department of hematology, oncology, hemostaseology and stem cell transplantation, Pauwelsstraße 30, 52074 Aachen, Allemagne. Electronic address: ejost@ukaachen.de.
Bull Cancer ; 106(1S): S1-S9, 2019 Jan.
Article em Fr | MEDLINE | ID: mdl-30580913
ABSTRACT
Allogeneic hematopoietic cell transplantation (HCT) is part of the standard of care for many hematological diseases. Over the last decades, significant advances in patient and donor selection, conditioning regimens as well as supportive care of patients undergoing allogeneic HCT leading to improved overall survival have been made. In view of many new treatment options in cellular and molecular targeted therapies, the place of allogeneic transplantation in therapy concepts must be reviewed. Most aspects of HCT are well standardized by national guidelines or laws as well as by certification labels such as FACT-JACIE. However, the requirements for human resources, construction and layout of a unit treating patients during the transplantation procedure and for different complications are not well defined. Here, we describe the process of planning a transplant unit in order to open a discussion that could lead to more precise guidelines in the field of personnel and infrastructural requirements for hospitals caring for people with severe immunosuppression.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Ambiente de Instituições de Saúde / Doenças Hematológicas Tipo de estudo: Guideline / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: Fr Revista: Bull Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Ambiente de Instituições de Saúde / Doenças Hematológicas Tipo de estudo: Guideline / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: Fr Revista: Bull Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
...